News of the index components FRANCE CAC MID & SMALL

Index

CACMS

QS0010989133

Market Closed - Euronext Paris 09:45:04 16/07/2024 pm IST			5-day change	1st Jan Change
13,613 ^PTS	-0.31%		+0.72%	+0.74%

12/07	Africa proposes WTO chief for second term, document shows	RE
25/06	Deadly battery plant fire highlights risks for South Korea's migrant workers	RE

News of the index components

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Atos: Onepoint welcomes board support ATO	11/06	CF
French IT Firm Atos Accepts Rescue Bid From Onepoint Consortium -- 2nd Update ATO	11/06	DJ
JCDECAUX : Deutsche Bank gives a Neutral rating DEC	11/06	ZD
ATOS : heavy dilution, Oddo BHF lowers its target ATO	11/06	CF
TF1 : Oddo BHF reiterates its buy recommendation TFI	11/06	CF
Transcript : Casino, Guichard-Perrachon S.A. - Shareholder/Analyst Call CO	11/06
Correction to Atos Rescue Bid Update Article ATO	11/06	DJ
Wendel Buys Minority Stake in Cybersecurity Company YesWeHack MF	11/06	MT
JCDecaux: Deutsche Bank downgrades, the stock stumbles DEC	11/06	CF
Viridien: a contract in high-performance computing VIRI	11/06	CF
Medincell Joins the Euronext Tech Leaders MEDCL	11/06	BU
Eurazeo: exclusive discussions with Oakley Capital RF	11/06	CF
Wavestone : presentation – Portzamparc Small & Mid Caps Conference (slideshow) WAVE	11/06	PU
Atos: has accepted the offer of the consortium led by Onepoint ATO	11/06	CF
France's Atos Accepts Rescue Bid From Onepoint Consortium -- Update ATO	11/06	DJ
Exail Technologies : Exail technologies joins the Euronext Tech Leaders segment dedicated to high-growth and leading technological companies EXA	11/06	AT
Atos Confirms Selection of Onepoint Consortium's Proposal for Debt Restructuring ATO	11/06	MT
Ipsen: FDA grants approval for treatment IPN	11/06	CF
EURAZEO : L’EQUIPE DE MANAGEMENT D’I-TRACING ET SAGARD NEWGEN ENTRENT EN DISCUSSIONS EXCLUSIVES EN VUE D’ACCUEILLIR OAKLEY CAPITAL COMME NOUVEL ACTIONNAIRE DE REFERENCE DU GROUPE RF	11/06	PU
EURAZEO : MANAGEMENT TEAM OF I-TRACING AND SAGARD NEWGEN HAVE ENTERED INTO EXCLUSIVE DISCUSSIONS TO WELCOME OAKLEY CAPITAL AS A REFERENCE SHAREHOLDER OF THE GROUP RF	11/06	PU
Wendel acquires a minority stake in YesWeHack MF	11/06	CF
Viridien Joins Forces with Ranch Computing to Supercharge the Digital Media Landscape VIRI	11/06	GL
Viridien Joins Forces with Ranch Computing to Supercharge the Digital Media Landscape VIRI	11/06	CI
Technip Energies to License Improved OXO Alcohol Technology with Mitsubishi Chemical TE	11/06	MT
Ipsen Secures US FDA's Accelerated Approval for Liver Disease Drug Iqirvo IPN	11/06	MT
WENDEL: Wendel Growth invests in YesWeHack, a leading Bug Bounty and Vulnerability Management Platform MF	11/06	GL
Atos Opts to Restructure via Debt Proposal of Onepoint Consortium ATO	11/06	MT
Viridien wins 20 MUSD contract to supply a Sercel GPR300 OBN solution for North Sea project VIRI	11/06	GL
Viridien Wins 20 Million Contract to Supply A Sercel GPR300 OBN Solution for North Sea Project VIRI	11/06	CI
Atos prefers Layani's offer to Kretinsky's ATO	11/06	RE
Atos picks Layani's consortium as preferred financial restructuring proposal ATO	11/06	RE
Market Update - June 11, 2024 ATO	11/06	GL
Antins Flagship Fund V, managed by Antin Infrastructure Partners SAS completed the acquisition of Portakabin Limited from Shepherd Building Group Ltd. ANTIN	11/06	CI
YesWeHack announced that it has received ?26 million in funding from Wendel, Adelie Advisors, Bpifrance Investissement SAS, Seventure Partners, Eiffel Investment Group S.A.S., Open CNP MF	11/06	CI
Cognigy GmbH announced that it has received ?93 million in funding from Eurazeo SE, Insight Venture Management, LLC, Deutsche Telekom Capital Partners Management GmbH, DN Capital (UK) LLP and other investors RF	11/06	CI
Genfit Partner Ipsen Gets FDA Accelerated Approval for Primary Biliary Cholangitis Treatment GNFT	11/06	MT
Ipsen's Rare Liver Disease Treatment Gets FDA OK IPN	11/06	DJ
GENFIT: Historic Milestone Achieved with U.S. FDA Accelerated Approval of Ipsen’s Iqirvo® for Primary Biliary Cholangitis GNFT	11/06	GL
US FDA grants accelerated approval to Genfit and Ipsen's liver disease drug IPN	11/06	RE
US FDA approves Genfit and Ipsen's liver disease drug IPN	11/06	RE